visit also QSynth Custom Synthesis
Vivimed Labs
| Uquifa announce creation of QSynth |
|
Uquifa SA is pleased to announce the creation of QSynth SA as its independent commercial subsidiary, with the primary mission to manage and improve its services for the CMO business to the Pharmaceutical Industry.
This once again demonstrates the strong commitment of Uquifa and of Vivimed labs, who recently acquired Uquifa, to consolidate Uquifa as one of the major suppliers of bulk APIs and advanced intermediates to the Pharmaceutical Industry; this will be supported by a significant investment plan by the group in each of its sites for the coming two years, to further expand capacity and keep the technology set to the highest standard.
Mark I. Robbins CEO QSYNTH S.A. and UQUIFA S.A. |